Understanding the relationship between units, milligrams, and concentration is not optional
Gradually increasing fibre intake helps prevent bloating and allows the digestive system to adjust
With flexible online care and brand-name medications, its a strong option for those seeking reliable weight-loss support
GLP-1 medications may carry risks including thyroid C-cell tumors (including thyroid cancer) and medullary thyroid carcinoma (MTC)
About ACHIEVE-3 and ACHIEVE clinical trial program ACHIEVE-3 (NCT06045221) is a Phase 3, 52-week, randomized, open-label trial evaluating the efficacy and safety of orforglipron compared with oral semaglutide in adults with type 2 diabetes inadequately controlled with metformin
Understanding your injection schedule helps maximize the therapy's effectiveness while minimizing the risk of side effects